BHCM
CRGX

Brevan Howard Capital Management’s CARGO Therapeutics CRGX Stock Holding History

Brevan Howard Capital Management’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-39,194
Closed -$160K – 1866
2025
Q1 		$160K Buy
+39,194
New +$262K ﹤0.01% 1016

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGV
TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return

Brevan Howard Capital Management's CRGX Position: Q2 2025 in Review

Brevan Howard Capital Management sold out of CARGO Therapeutics (CRGX) in Q2 2025, closing a stake of 39,194 shares — an estimated $160K sold.

Brevan Howard Capital Management first reported a position in CRGX in Q1 2025 and held it in 1 quarter. The position peaked at $160K in Q1 2025. 116 funds tracked by Wall St. Rank hold CRGX as of Q2 2025.

  • Brevan Howard Capital Management reported no remaining CARGO Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 39,194 CARGO Therapeutics shares in Q2 2025, an estimated $160K.
  • Brevan Howard Capital Management first reported a position in CARGO Therapeutics in Q1 2025 and held it in 1 quarter.
  • Brevan Howard Capital Management's CARGO Therapeutics position peaked at $160K in Q1 2025.
  • 116 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q2 2025.

Based on Brevan Howard Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.